Announcements
- Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC
- Oxurion Announces Results on the Annual Shareholders’ Meeting of 16 May 2024
- Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
- Important Advances in Oxurion's R&D Program on Geographic Atrophy secondary to AMD
- Publication Annual Report – Annual Shareholders' Meeting
- Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC
- Oxurion Receives EUR 450,000 in the framework of the Atlas Funding Program : Eleventh tranche fully issued and paid-up
- Postponement Annual Shareholders Meeting - Amendment financial calendar
- Information on the Total Number of Voting Rights (Denominator) following Conversion Notices from Atlas - Amended version
- Information on the Total Number of Voting Rights (Denominator) following Conversion Notices from Atlas
More ▼
Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.0001 |
---|---|
High | 0.0001 |
Low | 0.0001 |
Bid | 0.0001 |
Offer | -- |
Previous close | 0.0001 |
Average volume | 0.00 |
---|---|
Shares outstanding | 12.28bn |
Free float | 9.89bn |
P/E (TTM) | -- |
Market cap | 1.23m EUR |
EPS (TTM) | -0.023 EUR |
Data delayed at least 15 minutes, as of May 31 2024 07:14 BST.
More ▼